Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Bayer Execs Roth And Eckhardt On Current And Future Pharma Growth
Nubeqa, Kerendia Driving Revenue; New Launches On The Way
Feb 27 2025
•
By
Mandy Jackson
New launches and added indications will fuel growth in 2025 as Xarelto revenue declines
(Shutterstock)
More from Strategy
More from Scrip